Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
Launched by ODENSE UNIVERSITY HOSPITAL · Jan 23, 2012
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to monitor patients after they have received a kidney transplant. The goal is to see if using noninvasive tests—like analyzing blood, urine, and tissue samples—can help doctors better understand how well the transplant is working and improve patient outcomes. Researchers will track changes over time, looking at various genetic and protein markers to see if they can predict issues such as infections or rejection of the new kidney.
To participate in this study, individuals must be adults who have undergone a kidney transplant and are willing to provide informed consent. Throughout the trial, participants will undergo routine tests at several points in the first few years after their transplant. This trial is currently recruiting participants of all genders and ages starting from 65 years old. Being a part of this study may help contribute to better monitoring techniques for future kidney transplant patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients after kidney transplantation, male, female, informed consent
- Exclusion Criteria:
- • Deny of informed consent
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, Dk, Denmark
Patients applied
Trial Officials
Martin Tepel, Dr
Principal Investigator
Odense University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials